Psychological Implications of Covid-19: Lockdown and Beyond
PSYCHOLOGICAL IMPLICATIONS – LOCKDOWN AND AFTERWARDS Due to Covid-19, people saw an acute change in their behaviour and mental health during the lockdown period as well as after it, while moving towards normalcy. As mentioned, as a result of lockdown, people experienced emotional/mental trauma due to prolonged confinement in a ‘hostile’ home environment. Moreover, the […]
Dissecting the Role of CPCB During Covid-19 Pandemic
INTRODUCTION “I only feel angry when I see waste. When I see people throwing away things we could use.” – Mother Teresa After a decline in COVID cases in September, India saw a huge upsurge in the cases after March 2021 as a result of the second wave.[i] The second wave unleashed havoc on human life […]
Pfizer Lookout For A Partner For Drug Manufacturing
p { text-align:justify; }
CRISPR Patent Process And Its Applicability In The Covid Era
INTRODUCTION CRISPR technology is a targeted technique that allows researchers to modify genomes with unprecedented precision, efficiency, and flexibility. This technology is at the heart of a true biotechnology revolution, with huge implications for health, agriculture, and a variety of other sectors. On October 7, 2020, Professors Emmanuelle Charpentier and Jennifer Doudna were awarded the […]
IP Waiver and Covid-19 Vaccines
Since 2019, coronavirus hit the whole world and it is now for 2 years, we are facing this unfortunate pandemic. As of 27 October 2021, there is a total of 24.43cr cases and 49.61lakh deaths worldwide with the USA on top followed by India and Brazil. The figures are alarming but the ground situation is […]
Zooming Out On Compulsory Licensing Of Covid-19 Vaccines
The unnerving bio- catastrophe, the COVID-19 pandemic has brought an array of challenges for mankind. The COVID-19 scare at the global level is posing threat to human life and the governments are deeply divided over an effort to endorse a temporary patent waiver on COVID-19 vaccines and grant of compulsory licenses. What is Compulsory Licensing? […]
Premas Biotech and Oravax enter into licensing deal for commercialization of VLP injectable vaccine technology in India
Recently, Oravax Medical Inc., (“Oravax” has entered into a licensing agreement with Premas Biotech to make available for commercialization of Oravax’s virus-like particle (VLP) vaccine technology. Oravax is a joint venture between Oramed Pharmaceuticals Inc., a US-based company (the majority shareholder), and Gurugram, India-based life sciences company, Premas Biotech (“Premas”). While the terms of the […]
Premas Biotech and Oravax enter into licensing deal for commercialization of VLP injectable vaccine technology in India
Recently, Oravax Medical Inc., (“Oravax” has entered into a licensing agreement with Premas Biotech to make available for commercialization of Oravax’s virus-like particle (VLP) vaccine technology. Oravax is a joint venture between Oramed Pharmaceuticals Inc., a US-based company (the majority shareholder), and Gurugram, India-based life sciences company, Premas Biotech (“Premas”). While the terms of the license agreement […]
Patents and Public Health
Introduction Patents and public health is the most relevant topic of discussion when the whole world is fighting against the global pandemic, Covid-19. It is no doubt that granting patent protection to a drug is important and serves many purposes, but can we put the lives of millions of people at stake in this time […]
Covid-19 & Competition Act Of India
About Competition What does one understand by the word “Competition”? In common man’s language competition in the market would refer to rivalry between 2 entities selling similar products and/or services with the goal of achieving revenue, profit and market share. Thus it ensures that the entities involved with similar products compete on merits and not […]